tiprankstipranks
Tempest Therapeutics, Inc. (TPST)
:TPST
US Market

Tempest Therapeutics (TPST) Stock Forecast & Price Target

Compare
1,225 Followers
See the Price Targets and Ratings of:

TPST Financial Forecast

TPST Earnings Forecast

Next quarter’s earnings estimate for TPST is -$0.25 with a range of -$0.30 to -$0.19. The previous quarter’s EPS was -$0.41. TPST beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 42.17% of the time in the same period. In the last calendar year TPST has Outperformed its overall industry.
Next quarter’s earnings estimate for TPST is -$0.25 with a range of -$0.30 to -$0.19. The previous quarter’s EPS was -$0.41. TPST beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 42.17% of the time in the same period. In the last calendar year TPST has Outperformed its overall industry.
No data currently available

TPST Sales Forecast

Next quarter’s sales forecast for TPST is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. TPST beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 49.54% of the time in the same period. In the last calendar year TPST has Preformed in-line its overall industry.
Next quarter’s sales forecast for TPST is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. TPST beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 49.54% of the time in the same period. In the last calendar year TPST has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Scotiabank
$13
Buy
1411.63%
Upside
Reiterated
11/13/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: Quanterix (NASDAQ: QTRX), Nevro Corp (NYSE: NVRO) and Tempest Therapeutics (NASDAQ: TPST)
H.C. Wainwright
$47
Buy
5365.12%
Upside
Reiterated
11/13/24
Tempest Therapeutics: Promising Advancements and Strategic Partnerships Justify Buy Rating
Piper Sandler
$8$5
Buy
481.40%
Upside
Reiterated
11/13/24
Tempest Therapeutics price target lowered to $5 from $8 at Piper SandlerTempest Therapeutics price target lowered to $5 from $8 at Piper Sandler
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tempest Therapeutics

Which Analyst Should I Follow If I Want to Buy TPST and Sell After:
1 Month
xxx
Success Rate
3/9 ratings generated profit
33%
Average Return
+86.14%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of +86.14% per trade.
3 Months
xxx
Success Rate
2/9 ratings generated profit
22%
Average Return
+72.54%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 22.22% of your transactions generating a profit, with an average return of +72.54% per trade.
1 Year
Edward TenthoffPiper Sandler
Success Rate
2/10 ratings generated profit
20%
Average Return
-14.28%
reiterated a buy rating 3 months ago
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -14.28% per trade.
2 Years
xxx
Success Rate
3/10 ratings generated profit
30%
Average Return
-35.99%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 30.00% of your transactions generating a profit, with an average return of -35.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TPST Analyst Recommendation Trends

Rating
May 24
Jun 24
Aug 24
Oct 24
Nov 24
Strong Buy
8
6
9
9
9
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
6
9
9
9
In the current month, TPST has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TPST average Analyst price target in the past 3 months is $21.67.
Each month's total comprises the sum of three months' worth of ratings.

TPST Stock Forecast FAQ

What is TPST’s average 12-month price target, according to analysts?
Based on analyst ratings, Tempest Therapeutics, Inc.’s 12-month average price target is $21.67.
    What is TPST’s upside potential, based on the analysts’ average price target?
    Tempest Therapeutics, Inc. has 2419.77% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TPST a Buy, Sell or Hold?
          Tempest Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Tempest Therapeutics, Inc.’s price target?
            The average price target for Tempest Therapeutics, Inc. is $21.67. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $47.00 ,the lowest forecast is $5.00. The average price target represents 2419.77% Increase from the current price of $0.86.
              What do analysts say about Tempest Therapeutics, Inc.?
              Tempest Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of TPST?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis